The truth will out.
by Dr. Joseph Mercola STORY-AT-A-GLANCE An advisory panel to the U.S. Food and Drug Administration voted to grant emergency authorization to Merck’s oral COVID-19 pill molnupiravir (Lagevrio) — by a narrow 13-to-10 margin Among those who received the drug, the rate of all-cause hospitalization or death was 6.8%, compared to 9.7% in the placebo group […]
by Valerie Donaldson, MD New Oral Pharmaceutical Agents For Mild to Moderate COVID-19 As it is becoming more clear vaccines do not stop the spread of COVID-19, but may be instrumental in shortening the length of illness, symptoms, and decrease hospitalizations; two large pharmaceutical companies, Merck and Pfizer, have come forward with press releases regarding […]
by Dr. Joseph Mercola STORY AT-A-GLANCE One paper compared Merck’s data on molnupiravir against peer-reviewed data on ivermectin and found ivermectin has a low side effect profile, costs less than molnupiravir and is more effective against SARS-CoV-2 Clinical Trials data show Merck gathered 1,850 participants but released data on only 762 in the non-hospitalized arm […]
written by Paul Craig Roberts The criminal organization, Merck, announced today that they filed an “emergency use authorization” request with the company’s agent, the FDA, for an oral antiviral medicine for treating Covid-19. Former FDA commissioner and shill for Big Pharma, Scott Gottlieb, lobbied for the emergency use authorization on CNBC, declaring the untested pill […]